Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test

Anesthesia and Analgesia

Volumn 104, Issue 3, 2007, Pages 719-725

  Kang, Sinyoung ^a   Kim, Chi Hyo ^a,b   Lee, Heeseung ^a   Kim, Dong Yeon ^a   Han, Jong In ^a   Chung, Rack Kyung ^a   Lee, Guie Yong ^a  

^a Ewha Womans University   (South Korea)

^b Mokdong Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BUPIVACAINE; CANNABINOID RECEPTOR AGONIST; FORMALDEHYDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CATHETER; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FORMALDEHYDE; HUMANS; INJECTIONS, SPINAL; MALE; MORPHOLINES; NAPHTHALENES; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID;

EID: 33847231287     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000255291.38637.26     Document Type: Article

References (33)

1. Butterworth JF IV, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology 1990;72:711-34.
2. Akerman B, Arwestrom E, Post C. Local anesthetics potentiate spinal morphine antinociception. Anesth Analg 1988;67:943-8.
3. Nishiyama T, Hanaoka K. Intrathecal clonidine and bupivacaine have synergistic analgesia for acute thermally or inflammatory-induced pain in rats. Anesth Analg 2004;98:1056-61.
4. Paech MJ, Pavy TJ, Orlikowski CE, et al. Postoperative epidural infusion: a randomized, double-blind, dose-finding trial of clonidine in combination with bupivacaine and fentanyl. Anesth Analg 1997;84:1323-81.
5. Kalso E. Effects of intrathecal morphine, injected with bupivacaine, on pain after orthopaedic surgery. Br J Anaesth 1983;55:415-22.
6. Hanson AL, Hanson B, Matousek M. Epidural anesthesia for cesarean section. The effect of morphine-bupivacaine administered epidurally for intra and postoperative pain relief. Acta Obstet Gynecol Scand 1984;63:135-40.
7. Li J, Daughters RS, Bullis C, et al. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Pain 1999;81:25-33.
8. Herzberg U, Eliav E, Bennett GJ, Kopin IJ. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 1997;221:157-60.
9. Walker JM, Hohmann AG, Martin WJ, et al. The neurobiology of cannabinoid analgesia. Life Sci 1999;65:665-73.
10. Chaperon F, Thiebot MH. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 1999;13:243-81.
11. Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther 1992;262:10-18.
12. Martin WJ, Loo CM, Basbaum AI. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 1999;82:199-205.
13. Tsou K, Brown S, Sanudo-Pena MC, et al. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998;83:393-411.
14. Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002;66:101-21.
15. Wu WP, Xu XJ, Hao JX. Chronic lumbar catheterization of the spinal subarachnoid space. J Neurosci Methods 2004;133:65-9.
16. Kawamata T, Omote K, Yamamoto H, et al. Antihyperalgesic and side effects of intrathecal clonidine and tizanidine in a rat model of neuropathic pain. Anesthesiology 2003;98:1480-3.
17. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989;45:947-61.
18. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. 2nd ed. New York: Springer-Verlag, 1987.
19. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001;298:865-72.
20. Tjolsen A, Berge OG, Hunskaar S, et al. The formalin test: an evaluation of the method. Pain 1992;51:5-17.
21. Coderre TJ, Vaccarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990;535:155-8.
22. Yoon MH, Choi JI. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test. Anesthesiology 2003;99:701-7.
23. Nishiyama T, Hanaoka K. Midazolam can potentiate the analgesic effects of intrathecal bupivacaine on thermal- or inflammatory-induced pain. Anesth Analg 2003;96:1386-91.
24. Fraser HM, Chapman V, Dickenson AH. Spinal local anaesthetic actions on afferent evoked responses and wind-up of nociceptive neurons in the rat spinal cord: combination with morphine produces marked potentiation of antinociception. Pain 1992;49:33-41.
25. Strangman NM, Walker JM. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J Neurophysiol 1999;82:472-7.
26. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992;77:757-63.
27. Sugimoto M, Uchida I, Mashimo T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D- aspartate (NMDA) receptors. Br J Pharmacol 2003;138:876-82.
28. Crosby G. Local spinal cord blood flow and glucose utilization during spinal anesthesia with bupivacaine in conscious rats. Anesthesiology 1985;63:55-60.
29. Berenbaum MC. What is synergy? Pharmacol Rev 1989;41:93-141.
30. Scholz A. Mechanisms of local anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 2002;89:52-61.
31. 3H]quinuclydinyl benzylate binding to central muscarinic receptors. Eur J Pharmacol 1980;68:317-26.
32. Li DF, Bahar M, Cole G, Rosen M. Neurologic toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chlorprocaine in the rat. Br J Anaesth 1985;57:424-9.
33. Bengtsson M, Malmqvist LA, Edstrom HH. Spinal analgesia with glucose-free bupivacaine-effects of volume and concentration. Acta Anaesthesiol Scand 1984;28:583-6.